Page 3 - Gsk

US pledges up to $2.1 billion for Sanofi, GlaxoSmithKline Covid-19 vaccine

Glaxo shares traded 1.6 per cent higher in London, with Sanofi up 1.4 per cent in Paris

GSK profit misses as vaccine sales disappoint, stockpiling eases

The company said it still expects adjusted earnings per share for the year to decline in the range of 1% to 4%

GSK buys 10% stake of German biotech firm CureVac in $164-million deal

GSK and CureVac, backed by Bill Gates, will work on developing up to five so-called mRNA-based vaccines and monoclonal antibodies (mAbs) for infectious diseases, they said.

GSK in quest to be best, not first, in race for coronavirus vaccine

GSK, which is in seven collaborations with institutions or firms globally, only entered the clinical trial stage with one project on Friday

GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

The British drugmaker is working on its own COVID vaccine with Sanofi

GSK Pharma: Near term headwinds may keep stock prices under pressure

April sales were the worst among top drug players

Street signs: Banking stocks under pressure, FPI tally gets skewed and more

The performance of banking stocks is likely to weigh on the markets

Market Ahead, May 7: Top factors that could guide markets today

Hindustan Unilever will be in focus today as UK-based GSK will offload shares worth Rs 26,000 crore in the FMGC major

Coronavirus impact: Top pharma companies fare better during lockdown

New launches stagnate as fresh prescriptions dry up

Glaxo Consumer reports 6% rise in profit before tax for December quarter

The firm's operating revenue stood at Rs 1,159 crore - up 3.7 per cent YoY from Rs 1,117 crore

Pfizer planning initial public offering of GSK consumer venture in four yrs

Albert Bourla, CEO of Pfizer, discussed the time frame for the IPO at the JPMorgan Healthcare Conference in San Francisco on Tuesday

Legacy pharma brands spin gold for GSK, Pfizer; keep newcomers off the turf

Repositioning an old brand helps expand the footprint, say analysts

GSK credits STEER for Horlicks technology after year-long IP battle

STEER which was founded in 1993 by Padmanabhan has 5 global offices and 10 satellite offices, serving over 39 countries. It employs over 500 engineers, scientists and technicians across the globe

Drugmakers from Pfizer to GSK to hike US prices up to 10% on over 200 drugs

More price increases are expected to be announced later this week, which could affect the median and range.

Pharma firms plan awareness drive to battle cancer scare in antacid

Indian companies have also been hit in their global business.

GSK seeks licence to market baby-friendly HIV drug dolutegravir

If approved by regulators, the medicine will be the first new generation HIV medicine available in baby-friendly form

Drug major GSK sold off up to 10 tail-end brands in FY19 including Celin

According to the firm's FY19 annual report, it fetched Rs 5 crore during the year from the sale of brands

GSK to invest Rs 1,000 cr in Karnataka for new plant

Factory to commence production from 2018

GSK files potential $1 billion shingles vaccine for US approval

Shingrix is viewed by analysts as among the British drugmaker most promising experimental products

GSK puts Mumbai land on the block again

The land parcel is valued between Rs 1,400 crore and Rs 1,800 crore